Fleebs-Logo
Details werden geladen...

AstraZeneca's blood pressure pill approved, but competition could be around the corner

One of the key products underpinning AstraZeneca’s goal of hitting $80 billion in revenue by 2030 has been approved by the FDA, the drugmaker said Monday.

Ähnliche Seiten

https://www.biospace.com/fda/astrazeneca-wins-nod-for-blood-pressure-pill-opening-new-class-of-hypertension-drugs

AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs - BioSpace

https://www.biospace.com/fda/astrazeneca-wins-nod-for-blood-pressure-pill-opening-new-class-of-hypertension-drugs
https://economictimes.indiatimes.com/wealth/invest/nris-your-india-investments-could-be-losing-money-without-these-8-rules/slideshow/131166535.cms

NRIs: Your India investments could be losing money without these 8 rules - NRIs can invest in India, but it comes with real hurdles | The Economic Times

https://economictimes.indiatimes.com/wealth/invest/nris-your-india-investments-could-be-losing-money-without-these-8-rules/slideshow/131166535.cms